Competitive Problems in the Drug Industry Chloramphenicol (Chloromycetin)

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Antibiotics.

Bibliography.

Business ethics.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Washington, D.C.] [publisher not identified] 1979-1980

Summary:

CRS review, prepared by Irene Jillson and Vikki Zegel for the Subcom on Monopoly, Economic Concentration, and Anticompetitive Activities, analyzing issues highlighted during subcom 1968-69 hearings on the safety and efficacy of antibiotic chloramphenicol (Chloromycetin), and reviewing subsequent findings regarding chloramphenicol use and Government marketing and labeling actions

Includes summary and conclusions (pages 67-70), and bibliography of post-1969 literature (pages 77-81)

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Competitive Problems in the Drug Industry:. 79-S722-9

Publisher Number:

CRS-1979-SPR-0046

Access Restriction:

Restricted for use by site license